PROCEPT BioRobotics Corporation
PRCT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $224 | $136 | $75 | $34 |
| % Growth | 64.8% | 81.6% | 117.6% | – |
| Cost of Goods Sold | $87 | $65 | $38 | $19 |
| Gross Profit | $137 | $71 | $37 | $16 |
| % Margin | 61.1% | 52.2% | 49.4% | 46% |
| R&D Expenses | $62 | $48 | $29 | $19 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $171 | $132 | $89 | $51 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $234 | $180 | $118 | $70 |
| Operating Income | -$97 | -$109 | -$81 | -$54 |
| % Margin | -43% | -80.2% | -107.6% | -157.1% |
| Other Income/Exp. Net | $5 | $3 | -$6 | -$6 |
| Pre-Tax Income | -$91 | -$106 | -$87 | -$60 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$91 | -$106 | -$87 | -$60 |
| % Margin | -40.7% | -77.8% | -116.2% | -173.6% |
| EPS | -1.75 | -2.24 | -1.96 | -3.63 |
| % Growth | 21.9% | -14.3% | 46% | – |
| EPS Diluted | -1.75 | -2.24 | -1.96 | -3.63 |
| Weighted Avg Shares Out | 52 | 47 | 44 | 16 |
| Weighted Avg Shares Out Dil | 52 | 47 | 44 | 16 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11 | $8 | $2 | $0 |
| Interest Expense | $4 | $4 | $5 | $6 |
| Depreciation & Amortization | $5 | $4 | $3 | $3 |
| EBITDA | -$82 | -$98 | -$79 | -$51 |
| % Margin | -36.5% | -72% | -105.5% | -147.1% |